Ovarian carcinoma has a poor prognosis despite current therapies. In search for a new adjuvant therapy, the possibilities for Natural Killer cell therapy are explored in vitro and in vivo. This grant creates the opportunity to strengthen and broaden the acquired evidence on NK cell function, in workup to a clinical trial.
This project is a unique collaboration between the gynecologic oncology research group of Leon Massuger, theme Women's Cancers and the immunotherapy research group of Harry Dolstra and Joop Jansen, theme Cancer development and immune defence.
<< back to overview news items